drugset / Trial / NCT01622998

Self-directed Titrated Transdermal Nicotine Patch Versus Standard Treatment for Smoking Cessation

NCT01622998

RandomizedParallel-groupOpen-labelTreatment

Summary

The primary aim of this research study is to determine whether titrated, patient-directed transdermal patch NRT, based on smoking history and symptoms of nicotine withdrawal, improves long-term rates of smoking cessation in patients motivated to quit smoking when compared to patients using the standard transdermal NRT patch protocol. The following hypothesis will be tested: CO-validated continuous abstinence rate at 52 weeks post target quit date will be higher for the titrated, self-directed NRT group compared to the standard NRT treatment group.

Timeline

Start
2011-01
Primary completion
2014-08
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 4 mg Other
Subject Nicotine Unknown 7 mg Other
Subject Nicotine Unknown 14 mg Other
Subject Nicotine Unknown 21 mg Other

Indications

No indication recorded.